Brief: Lisata Therapeutics To Be Acquired By Kuva Labs For $4.00 Per Share In An All-Cash Tender Offer
21/01/2026 12:06
Jan 21 (Reuters) - Lisata Therapeutics Inc LSTA.O: LISATA THERAPEUTICS ENTERS INTO TERM SHEET TO BE ACQUIRED BY KUVA LABS FOR $4.00 PER SHARE IN AN ALL-CASH TENDER OFFER Source text: ID:nGNX31bNYF Further company coverage: LSTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco